Abimbola Johnson, DPM
Foot & Ankle Surgery · Saint Paul, MNNPI 1659857654
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.1%), education and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Arthrex at 30.3% of the total. Reporting peaked in 2022 at $7,746 and has fallen 93.0% since, to $546 in 2025.
Across 86 payments — averaging $133.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Stryker$3K
- Treace Medical Concepts, Inc.$2K
- Micromed Inc$1K
- Paragon 28, Inc.$1K
- Johnson & Johnson$343
- plus $553 from 8 others
What the payments were for
- Travel & lodging$2,73824%
- Food & beverage$4,49939%
- Education$4,28237%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 11 | $3,492 |
| Stryker(2 entities) | 26 | $2,553 |
| Treace Medical Concepts, Inc. | 28 | $2,369 |
| Micromed Inc | 1 | $1,200 |
| Paragon 28, Inc. | 2 | $1,010 |
| Johnson & Johnson | 4 | $343 |
| Alafair Biosciences, Inc. | 3 | $302 |
| Bioventus LLC | 3 | $65 |
| Tactile Systems Technology Inc | 2 | $43 |
| Integra Lifesciences Corporation | 2 | $38 |
| Mimedx Group, Inc. | 1 | $35 |
| Organogenesis Inc. | 1 | $28 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Melinta Therapeutics, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,413
- Product Portfolio$1,010
- PROstep$682
- VARIAX$545
- ANCHORAGE$374
- EASY CLIP$374
- MOTOBAND$264
- VersaWrap$239
- ASNIS$163
- TMC NANOPLASTY SYSTEM$155
- 4FUSION$147
- MOTOBAND CP$146
- NA$146
- FIXOS$126
- PROPHECY$110
How this compares
$11,519 in reported general payments places this provider in the 80th percentile of 102 foot & ankle surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 20 | $440 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $127 |
| Naproxen | 23 | $44 |
| Oxycodone Hcl | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Saint Paul
- Troy BoffeliSaint Paul$1.7M
- Collin MesserlySaint Paul$50K
- Samantha LuerSaint Paul$5K
- Johannes CoetzeeEdina$4.7M
- Jeffrey SeyboldEdina$270K
- Kyle AbbenSt Louis Park$130K
- Ryan ReinkingDuluth$48K
- Kevin MahoneyMarshall$39K
- Bethany StaehnkeCrookston$27K
- Amber WibbelsRoseau$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.